Huber, K; Delle Karth, G; Frank, H; Gremmel, T; Madl, C; Niessner, A; Neunteufl, T; Pirker, W; Watschinger, B; Weidinger, F; Weiss, T; Hoppe, U; Auer, J; Binder, RK; Siostrzonek, P; Steinwender, C; Sturmberger, T; Vosko, M; Wallner, H; Zweiker, R; Alber, H; Dritan, K; Kirsch, A; Kneihsl, M; Raggam, R; Scherr, D; Stadlbauer-Kollner, V; Zirlik, A.
Oral Anticoagulation and antithrombotic Therapy in Patients with Atrial Fibrillation after percutaneous Coronary Intervention - with special Reference to Dabigatran.
J KARDIOL. 2020; 27: 3-12.
Web of Science